TY - JOUR
T1 - Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis
T2 - A dermatologist and nail expert group consensus
AU - Rigopoulos, Dimitrios
AU - Baran, Robert
AU - Chiheb, Soumiya
AU - Daniel, Carlton Ralph
AU - Di Chiacchio, Nilton
AU - Gregoriou, Stamatis
AU - Grover, Chander
AU - Haneke, Eckart
AU - Iorizzo, Matilde
AU - Pasch, Marcel
AU - Piraccini, Bianca Maria
AU - Rich, Phoebe
AU - Richert, Bertrand
AU - Rompoti, Natalia
AU - Rubin, Adam I.
AU - Singal, Archana
AU - Starace, Michela
AU - Tosti, Antonella
AU - Triantafyllopoulou, Ioanna
AU - Zaiac, Martin
N1 - Publisher Copyright:
© 2019 American Academy of Dermatology, Inc.
PY - 2019/7
Y1 - 2019/7
N2 - Nail involvement in psoriasis is common, and the severity of it does not always parallel the intensity of cutaneous disease. We created a consensus group, of which the aim was to provide practical recommendations for the treatment of nail psoriasis in patients without skin psoriasis or with mild skin lesions with no indication for a systemic treatment. This collaborative process was conducted by an international panel of dermatologists with special expertise in nail disorders, using formal consensus methods. During this process, the panel strived to establish an agreement regarding the definition of nail psoriasis, the severity of nail psoriasis, and treatment response. Treatment recommendations are provided regarding nail psoriasis severity and matrix or bed involvement. Few-nail disease was considered as nail psoriasis affecting ≤3 nails. In the case of matrix involvement only, intralesional steroid injections were considered the treatment of choice. Topical steroids alone or in combination with topical vitamin D analogues were suggested for nail psoriasis limited to the nail bed. For the systemic treatment of nail psoriasis acitretin, methotrexate, cyclosporine, small molecules, and biologics may be employed.
AB - Nail involvement in psoriasis is common, and the severity of it does not always parallel the intensity of cutaneous disease. We created a consensus group, of which the aim was to provide practical recommendations for the treatment of nail psoriasis in patients without skin psoriasis or with mild skin lesions with no indication for a systemic treatment. This collaborative process was conducted by an international panel of dermatologists with special expertise in nail disorders, using formal consensus methods. During this process, the panel strived to establish an agreement regarding the definition of nail psoriasis, the severity of nail psoriasis, and treatment response. Treatment recommendations are provided regarding nail psoriasis severity and matrix or bed involvement. Few-nail disease was considered as nail psoriasis affecting ≤3 nails. In the case of matrix involvement only, intralesional steroid injections were considered the treatment of choice. Topical steroids alone or in combination with topical vitamin D analogues were suggested for nail psoriasis limited to the nail bed. For the systemic treatment of nail psoriasis acitretin, methotrexate, cyclosporine, small molecules, and biologics may be employed.
KW - consensus
KW - guidelines
KW - intralesional steroid injection
KW - nail psoriasis
KW - nail psoriasis recommendation
KW - nail psoriasis treatment
UR - http://www.scopus.com/inward/record.url?scp=85067438528&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067438528&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2019.01.072
DO - 10.1016/j.jaad.2019.01.072
M3 - Review article
AN - SCOPUS:85067438528
SN - 0190-9622
VL - 81
SP - 228
EP - 240
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -